About Focus DX
Focus DX is a Healthcare company based in Cypress (United States) founded in 1978, and was acquired by DiaSorin in March 2016. Diagnostic assays and reagents for infectious diseases are developed. Its focus areas include Life Sciences, Clinical Genomics, Amplification Based and PCR. Its legal entity is Focus Diagnostics, Inc. Its competitors include DermTech, Inflammatix and Karius; 3 of its 3 listed competitors have raised funding.
Company details
Focus Diagnostics was founded in 1978 and is based in Cypress, United States. Diagnostic assays and reagents for infectious diseases are developed by the company within the healthcare sector. The flagship Integrated Cycler serves as a benchtop real-time PCR instrument compatible with proprietary Simplexa Molecular assays. Solutions for diagnosing respiratory infections, sexually transmitted diseases, vector-borne diseases, and hospital-associated infections are provided.
- Headquarters Cypress, United States
- Stage Acquired
- SectorsHealthcare
- Website focusdx.com
- Social LinkedIn
- Acquired by DiaSorin (Mar 2016)
- Legal Name Focus Diagnostics, Inc.
Investors in Focus DX
Focus DX has secured backing from 1 investor. Prominent investors backing the company include DiaSorin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Reagent kits for in vitro diagnostics are developed and commercialized. | 1968 | diasorin.com | Saluggia, Italy |
Investor details for Focus DX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Focus DX
2 dated milestones of Focus DX across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Focus DX is founded.
- Exit Acquired by DiaSorin.
Competitors of Focus DX
Focus DX has 3 listed competitors in our database, 3 of them funded. They include DermTech, Inflammatix and Karius.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases |
Detailed competitors of Focus DX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Focus DX
Websites that share an audience with Focus DX (focusdx.com).
Websites whose visitors overlap most with Focus DX. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| questdiagnostics.com | 100% | 14.4M | #2,905 | View details | |
| quidel.com | 83% | #5,902,749 | View details | ||
| topogen.com | 83% | 3.9K | #4,806,681 | View details | |
| cepheid.com | 64% | 117.9K | #496,659 | View details | |
| oraldna.com | 57% | 7.1K | #3,709,579 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Focus DX
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Focus DX (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Focus DX
Focus DX was founded in 1978.
Focus DX is headquartered in Cypress, United States. It is registered at Cypress, California, United States.
Focus Diagnostics was founded in 1978 and is based in Cypress, United States. Diagnostic assays and reagents for infectious diseases are developed by the company within the healthcare sector. The flagship Integrated Cycler serves as a benchtop real-time PCR instrument compatible with proprietary Simplexa Molecular assays. Solutions for diagnosing respiratory infections, sexually transmitted diseases, vector-borne diseases, and hospital-associated infections are provided.
Focus DX's top competitors include Inflammatix, DermTech and Karius.
Focus DX has 1 investor. Key investors include DiaSorin.
Focus DX operates through Focus Diagnostics, Inc..
Yes. Focus DX was acquired by DiaSorin in March 2016.